Iodide transport and breast cancer

• Published in: Journal of endocrinology Vol. 227; no. 1; pp. R1 - R12
• Main Authors: Poole, Vikki L, McCabe, Christopher J
• Format: Journal Article
• Language: English
• Published: England Bioscientifica Ltd 01.10.2015
• Subjects: Animals; Biological Transport; Breast - metabolism; Breast Neoplasms - metabolism; Female; Humans; Iodides - metabolism; Lactation; Membrane Transport Proteins - chemistry; Membrane Transport Proteins - metabolism; Models, Biological; Monocarboxylic Acid Transporters - genetics; Monocarboxylic Acid Transporters - metabolism; Neoplasm Proteins - chemistry; Neoplasm Proteins - metabolism; Review; Sulfate Transporters; Symporters - chemistry; Symporters - metabolism; sodium-coupled monocarboxylate transporter (SMCT); breast cancer; radioiodide; iodide transport; sodium iodide symporter (NIS); pendrin
• ISSN: 0022-0795; 1479-6805; 1479-6805
• DOI: 10.1530/JOE-15-0234

Breast cancer is the second most common cancer worldwide and the leading cause of cancer death in women, with incidence rates that continue to rise. The heterogeneity of the disease makes breast cancer exceptionally difficult to treat, particularly for those patients with triple-negative disease. To address the therapeutic complexity of these tumours, new strategies for diagnosis and treatment are urgently required. The ability of lactating and malignant breast cells to uptake and transport iodide has led to the hypothesis that radioiodide therapy could be a potentially viable treatment for many breast cancer patients. Understanding how iodide is transported, and the factors regulating the expression and function of the proteins responsible for iodide transport, is critical for translating this hypothesis into reality. This review covers the three known iodide transporters – the sodium iodide symporter, pendrin and the sodium-coupled monocarboxylate transporter – and their role in iodide transport in breast cells, along with efforts to manipulate them to increase the potential for radioiodide therapy as a treatment for breast cancer.